Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with Clinical High Risk, Early Psychosis, or First Episode Psychosis. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at investigate neural markers in the cerebellar-cortical circuitry that predict treatment response to antipsychotics in first-episode psychosis for people with Psychosis or Acute. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether MDMA 40mg can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Xanomeline and Trospium Chloride Capsules can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia. Taking part may give some people access to Xanomeline/trospium chloride, but direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Paranoia or psychosis. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether ML-007C-MA can help people with Psychosis Associated With Alzheimer's Disease. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Acute (24-hour) abstinence can help people with Acute Abstinence From Cigarettes vs E-cigarettes. Participants take part in Acute (24-hour) abstinence and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Treatment-resistant Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Intracranial electrodes can help people with Schizophrenia Disorders, Mental Disorder, or psychosis. Participants take part in Intracranial electrodes and complete follow-up assessments.
This study is looking at whether an online mindfulness program can help people with Schizophrenia Disorder, Schizoaffecitve Disorder, or Aggression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Normobaric Oxygen can help people with Psychosis, Schizophrenia, or First-episode Psychosis. Participants take part in Normobaric Oxygen and complete follow-up assessments.
This study is comparing 3 Minute iTBS to the L DLPFC with Precision Brain Stimulation for Cannabis Users with Healthy Controls for people with Cannabis Use, Schizophrenia, Psychosis, or Rtms. Participants receive 3 Minute iTBS to the L DLPFC or Precision Brain Stimulation for Cannabis Users with Healthy Controls and complete study visits and assessments.
This study is looking at whether Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) can help people with Schizophenia Disorder or schizoaffective disorder. Participants take part in Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) and complete follow-up assessments.
This study is looking at evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia Disorders. Taking part may give some people access to Music video game, but direct benefit is not guaranteed.
This study is looking at be the first to comprehensively examine the health impact of social isolation in SZ for people with Schizophrenia and Related Disorders. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.